» Authors » F Richards

F Richards

Explore the profile of F Richards including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 57
Citations 546
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lakwo T, Garms R, Wamani J, Tukahebwa E, Onapa A, Tukesiga E, et al.
Acta Trop . 2016 Dec; 167:128-136. PMID: 28034767
Uganda is the only country in sub-Saharan Africa whose onchocerciasis elimination programme extensively uses vector control and biannual treatment with ivermectin. The purpose of this study was to assess the...
2.
Lakwo T, Garms R, Rubaale T, Katabarwa M, Walsh F, Habomugisha P, et al.
Acta Trop . 2013 Mar; 126(3):218-21. PMID: 23458325
The Itwara onchocerciasis focus is located around the Itwara forest reserve in western Uganda. In 1991, annual treatments with ivermectin started in the focus. They were supplemented in 1995 by...
3.
Cupp E, Sauerbrey M, Richards F
Acta Trop . 2010 Aug; 120 Suppl 1:S100-8. PMID: 20801094
We review and analyze approaches over a 65 year period that have proven successful for onchocerciasis control in several different epidemiological settings. These include vector control with the goal of...
4.
Alderton W, Berghmans S, Butler P, Chassaing H, Fleming A, Golder Z, et al.
Xenobiotica . 2010 Jun; 40(8):547-57. PMID: 20528625
This study examined the accumulation and metabolism of a number of drugs and commonly used probes for human cytochrome P450s (CYPs) in zebrafish larvae under conditions relevant to pharmacological and...
5.
6.
Blackstock A, Richards F, White D, Lesser G
Clin Lung Cancer . 2004 Jan; 1(2):153-4. PMID: 14733668
No abstract available.
7.
Blackstock A, Acostamadiedo J, Lesser G, Richards F, Case L, White D
Clin Lung Cancer . 2004 Jan; 2(1):62-6. PMID: 14731342
Pyrazine diazohydroxide (NSC 361456) (PZDH) was selected for further development after demonstrating more stability than its parent compound and significant antitumor activity in a number of in vivo tumor models....
8.
Gerrard G, Prestwich R, Edwards A, Russon L, Richards F, Johnston C, et al.
Clin Oncol (R Coll Radiol) . 2003 Oct; 15(7):422-8. PMID: 14570092
Aims: Trials have shown that patients with multiple-brain metastases and poor prognostic features have a short median survival after whole-brain radiotherapy (WBRT). Quality of life (QoL) and other parameters to...
9.
Thieben M, Duggins A, Good C, Gomes L, Mahant N, Richards F, et al.
Brain . 2002 Jul; 125(Pt 8):1815-28. PMID: 12135972
Putative neuroprotective agents in Huntington's disease may have particular application before brain pathology becomes manifest clinically. If these agents were to be tested in clinical trials, a reliable marker of...
10.
Richards F, Hopkins D, Cupp E
Lancet . 2000 Jul; 355(9216):1663-4. PMID: 10905239
No abstract available.